This item is authorised by the following title:
sch 1 (item 1) of the Therapeutic Goods (Guidelines for Multi-Site Licences) Instrument 2020
s 50 of the Legislation Act 2003
When documents are presented to the Australian Parliament for scrutiny, they are said to have been tabled.